FDA's Woodcock on New Unit to Boost Drug Oversight

Feb. 14 (Bloomberg) -- Janet Woodcock, director of the U.S. Food and Drug Administration's Center for Drug Evaluation and Research, speaks about the agency's decision to form a new unit to improve the FDA's scrutiny of brand-name, generic and over-the-counter drugs. Woodcock speaks at the Bloomberg 2014 State of Health Care summit in New York. (Source: Bloomberg)
Does Apple TV Need a Revamp?
15:56 - Homebrew VC Partner Hunter Walk, Technalysis Founder Bob O’Donnell and IDC Chief Research Officer Crawford Del Prete discuss Apple to unveil a new TV box this fall and the future of Apple’s streaming service. They speak with Bloomberg’s Emily Chang on “Bloomberg West.” (Source: Bloomberg)
  • Why Would Microsoft Invest in Uber?
  • Why U.S. Wage Growth Has Screeched to a Halt
  • The China Slowdown Felt Around the World